Stephen W. Gutkin

Statistics

Publications

Citations

369

H-Index

Active since

2001

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

EveryCat Health Foundation

Eli Lilly (United States)

Stephen W. Gutkin is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacotherapy, medicine, and lipid-lowering therapy.

Publications per year

2001–2014

Publications

Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study

Éric Van Ganse, Laurent Laforest, E. Alemao et al. · Current Medical Research and Opinion · 2005 · 88 citations

Pharmacy, Cardiology, Pharmacotherapy +16

Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe–statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia

Gerd Assmann, Frank Kannenberg, Dena Rosen Ramey et al. · Current Medical Research and Opinion · 2007 · 59 citations

Life Sciences, Pharmacology, Pharmacotherapy +15

Correlates of alcohol use in adults with ADHD and comorbid alcohol use disorders: exploratory analysis of a placebo-controlled trial of atomoxetine

Timothy E. Wilens, Lenard A. Adler, Yoko Tanaka et al. · Current Medical Research and Opinion · 2011 · 56 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +16

Time courses of improvement and symptom remission in children treated with atomoxetine for attention-deficit/hyperactivity disorder: analysis of Canadian open-label studies

R. A. Dickson, Ellen Maki, Christopher Gibbins et al. · Child and Adolescent Psychiatry and Mental Health · 2011 · 49 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +17

Sexual Satisfaction in Men with Erectile Dysfunction: Correlates and Potential Predictors

Stanley E. Althof, Stephen W. Gutkin, Mark Belger et al. · The Journal of Sexual Medicine · 2009 · 38 citations

Medicine, Psychology, Urology +15

1–5 of 9